FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Richard Mailman

Research Profile

Living Beings

Chemicals & Drugs

Anatomy

Concepts & Ideas

Drug Dose Response Relationship

Procedures

Radioligand Assay

Physiology

Activities & Behaviors

Animal Behavior

Co-author Network

Publications

TOP 3
Mechelle M Lewis; Richard B Mailman; Nisargkumar Patel; Michele L Shaffer; Guangwei Du; Michal Kidacki; Xuemei Huang
Higher iron in the red nucleus marks Parkinson's dyskinesia.
Guangwei Du; Honglei Chen; Mechelle M Lewis; Richard B Mailman; Michele L Shaffer; Qing X Yang; Xuemei Huang
Serum cholesterol and nigrostriatal R2* values in Parkinson's disease.
Jianjun Gao; Albert Russell Hollenbeck; Xuemei Huang; Rui Liu; Richard B Mailman; Yikyung Park; Arthur Schatzkin; Honglei Chen
Apolipoprotein E genotypes and the risk of Parkinson disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Richard Mailman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Mechelle M Lewis; Richard B Mailman; Nisargkumar Patel; Michele L Shaffer; Guangwei Du; Michal Kidacki; Xuemei Huang
Higher iron in the red nucleus marks Parkinson's dyskinesia.
Neurobiology of aging 2013;34(5):1497-503.
2012: Guangwei Du; Honglei Chen; Mechelle M Lewis; Richard B Mailman; Michele L Shaffer; Qing X Yang; Xuemei Huang
Serum cholesterol and nigrostriatal R2* values in Parkinson's disease.
PloS one 2012;7(4):e35397.
2011: Jianjun Gao; Albert Russell Hollenbeck; Xuemei Huang; Rui Liu; Richard B Mailman; Yikyung Park; Arthur Schatzkin; Honglei Chen
Apolipoprotein E genotypes and the risk of Parkinson disease.
Neurobiology of aging 2011;32(11):2106.e1-6.
2011: Mechelle M Lewis; G Du; S Sen; A Kawaguchi; Y Truong; S Lee; Richard B Mailman; Xuemei Huang
Differential involvement of striato- and cerebello-thalamo-cortical pathways in tremor- and akinetic/rigid-predominant Parkinson's disease.
Neuroscience 2011;177():230-9.
2010: Honglei Chen; X Huang; X Guo; Richard B Mailman; Y Park; F Kamel; D M Umbach; Q Xu; Albert Russell Hollenbeck; A Schatzkin; A Blair
Smoking duration, intensity, and risk of Parkinson disease.
Neurology 2010;74(11):878-84.
2010: Xuemei Huang; Honglei Chen; Helen Petrovitch; Richard B Mailman; George Ross
Reply: Plasma cholesterol and Parkinson's disease: Is the puzzle only apparent?
Movement disorders : official journal of the Movement Disorder Society 2010;25(1):137.
2010: Richard B Mailman; Vishakantha Murthy
Ligand functional selectivity advances our understanding of drug mechanisms and drug discovery.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2010;35(1):345-6.
2009: Mechelle M Lewis; A B Smith; Martin Styner; Hongbin Gu; R Poole; Hongtu Zhu; Y Li; X Barbero; S Gouttard; M J McKeown; Richard B Mailman; Xuemei Huang
Asymmetrical lateral ventricular enlargement in Parkinson's disease.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2009;16(4):475-81.
2009: Justin T Brown; Andrew Kant; Richard B Mailman
Rapid, semi-automated, and inexpensive radioimmunoassay of cAMP: application in GPCR-mediated adenylate cyclase assays.
Journal of neuroscience methods 2009;177(2):261-6.
2008: Xuemei Huang; Robert D Abbott; Helen Petrovitch; Richard B Mailman; George Ross
Low LDL cholesterol and increased risk of Parkinson's disease: prospective results from Honolulu-Asia Aging Study.
Movement disorders : official journal of the Movement Disorder Society 2008;23(7):1013-8.
2007: Richard B Mailman
GPCR functional selectivity has therapeutic impact.
Trends in pharmacological sciences 2007;28(8):390-6.
2007: Qiwen Mu; Kevin Johnson; Paul S Morgan; Emily Grenesko; Christine E Molnar; Berry Anderson; Ziad Nahas; F Andrew Kozel; Samet Kose; Michael B Knable; Prabhavathi Fernandes; David E Nichols; Richard B Mailman; Mark Stork George
A single 20 mg dose of the full D1 dopamine agonist dihydrexidine (DAR-0100) increases prefrontal perfusion in schizophrenia.
Schizophrenia research 2007;94(1-3):332-41.
2007: Mark Stork George; Christine E Molnar; Emily Grenesko; Berry Anderson; Qiwen Mu; Kevin Johnson; Ziad Nahas; Michael B Knable; Prabhavathi Fernandes; Jorge L Juncos; Xuemei Huang; David E Nichols; Richard B Mailman
A single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophrenia.
Schizophrenia research 2007;93(1-3):42-50.
2007: Mechelle M Lewis; C G Slagle; A B Smith; Y Truong; P Bai; M J McKeown; Richard B Mailman; Aysenil Belger; Xuemei Huang
Task specific influences of Parkinson's disease on the striato-thalamo-cortical and cerebello-thalamo-cortical motor circuitries.
Neuroscience 2007;147(1):224-35.
2007: Xuemei Huang; Honglei Chen; William C Miller; Richard B Mailman; Jennifer L Woodard; Peter C Chen; Dong Xiang; Richard Murrow; Yi-Zhe Wang; Charles Poole
Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2007;22(3):377-81.
2007: Jessica P Ryman-Rasmussen; Adam Griffith; Scott Oloff; Nagarajan Vaidehi; Justin T Brown; William A Goddard; Richard B Mailman
Functional selectivity of dopamine D1 receptor agonists in regulating the fate of internalized receptors.
Neuropharmacology 2007;52(2):562-75.
2007: Richard B Mailman; Xuemei Huang
Dopamine receptor pharmacology.
Handbook of clinical neurology 2007;83():77-105.
2007: Jonathan D Urban; William Clarke; Mark von Zastrow; David E Nichols; Brian Kobilka; HAREL WEINSTEIN; Jonathan A Javitch; Bryan L Roth; Arthur Christopoulos; Patrick M Sexton; Keith J Miller; Michael Spedding; Richard B Mailman
Functional selectivity and classical concepts of quantitative pharmacology.
The Journal of pharmacology and experimental therapeutics 2007;320(1):1-13.
2007: Jonathan D Urban; Gabriel Vargas; Mark von Zastrow; Richard B Mailman
Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2007;32(1):67-77.
2006: Sarah K Leonard; Penelope Ferry-Leeper; Richard B Mailman
Low affinity binding of the classical D1 antagonist SCH23390 in rodent brain: potential interaction with A2A and D2-like receptors.
Brain research 2006;1117(1):25-37.
2006: Mechelle M Lewis; Xuemei Huang; David E Nichols; Richard B Mailman
D1 and functionally selective dopamine agonists as neuroprotective agents in Parkinson's disease.
CNS & neurological disorders drug targets 2006;5(3):345-53.
2005: Scott Oloff; Richard B Mailman; Alexander Tropsha
Application of validated QSAR models of D1 dopaminergic antagonists for database mining.
Journal of medicinal chemistry 2005;48(23):7322-32.
2005: Stephanie Padilla; Renée S Marshall; Deborah L Hunter; Sharon Oxendine; Virginia C Moser; Stanley B Southerland; Richard B Mailman
Neurochemical effects of chronic dietary and repeated high-level acute exposure to chlorpyrifos in rats.
Toxicological sciences : an official journal of the Society of Toxicology 2005;88(1):161-71.
2005: Jessica P Ryman-Rasmussen; David E Nichols; Richard B Mailman
Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists.
Molecular pharmacology 2005;68(4):1039-48.
2004: Elaine A Gay; Jonathan D Urban; David E Nichols; Gerry S Oxford; Richard B Mailman
Functional selectivity of D2 receptor ligands in a Chinese hamster ovary hD2L cell line: evidence for induction of ligand-specific receptor states.
Molecular pharmacology 2004;66(1):97-105.
2004: Russell A Grubbs; Mechelle M Lewis; Connie Owens-Vance; Elaine A Gay; Amy Jassen; Richard B Mailman; David E Nichols
8,9-dihydroxy-1,2,3,11b-tetrahydrochromeno[4,3,2,-de]isoquinoline (dinoxyline), a high affinity and potent agonist at all dopamine receptor isoforms.
Bioorganic & medicinal chemistry 2004;12(6):1403-12.
2004: Sing-Yuen Sit; Kai Xie; Swanee Jacutin-Porte; Kenneth M Boy; James Seanz; Matthew T Taber; Amit G Gulwadi; Carolyn D Korpinen; Kevin D Burris; Thaddeus F Molski; Elaine Ryan; Cen Xu; Todd Verdoorn; Graham Johnson; David E Nichols; Richard B Mailman
Synthesis and SAR exploration of dinapsoline analogues.
Bioorganic & medicinal chemistry 2004;12(4):715-34.
2003: Sarah K Leonard; Carl M Anderson; Jean E Lachowicz; David W Schulz; Clinton D Kilts; Richard B Mailman
Amygdaloid D1 receptors are not linked to stimulation of adenylate cyclase.
Synapse (New York, N.Y.) 2003;50(4):320-33.
2003: David A Shapiro; Sean Renock; Elaine Arrington; Louis A Chiodo; Li-Xin Liu; David R Sibley; Bryan L Roth; Richard B Mailman
Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2003;28(8):1400-11.
2003: Amjad M Qandil; Mechelle M Lewis; Amy Jassen; Sarah K Leonard; Richard B Mailman; David E Nichols
Synthesis and pharmacological evaluation of substituted naphth[1,2,3-de]isoquinolines (dinapsoline analogues) as D1 and D2 dopamine receptor ligands.
Bioorganic & medicinal chemistry 2003;11(7):1451-64.
2002: Candace Andersson; Robert M Hamer; Cindy P Lawler; Richard B Mailman; Jeffrey A Lieberman
Striatal volume changes in the rat following long-term administration of typical and atypical antipsychotic drugs.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;27(2):143-51.
2002: Jason D Kilts; Hilary S Connery; Elaine G Arrington; Mechelle M Lewis; Cindy P Lawler; Gerry S Oxford; Karen L O'Malley; Richard D Todd; Bonita L Blake; David E Nichols; Richard B Mailman
Functional selectivity of dopamine receptor agonists. II. Actions of dihydrexidine in D2L receptor-transfected MN9D cells and pituitary lactotrophs.
The Journal of pharmacology and experimental therapeutics 2002;301(3):1179-89.
2002: David M Mottola; Jason D Kilts; Mechelle M Lewis; Hilary S Connery; Q David Walker; Sara R Jones; Raymond G Booth; Deborah K Hyslop; Monford Piercey; R Mark Wightman; Cindy P Lawler; David E Nichols; Richard B Mailman
Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase.
The Journal of pharmacology and experimental therapeutics 2002;301(3):1166-78.
2001: Richard B Mailman; Xuemei Huang; David E Nichols
Parkinson's disease and D1 dopamine receptors.
Current opinion in investigational drugs (London, England : 2000) 2001;2(11):1582-91.
2001: S Miyamoto; Richard B Mailman; Jeffrey A Lieberman; Gary E Duncan
Blunted brain metabolic response to ketamine in mice lacking D(1A) dopamine receptors.
Brain research 2001;894(2):167-80.
2001: D M Montague; C D Striplin; J S Overcash; J Drago; Cindy P Lawler; Richard B Mailman
Quantification of D1B(D5) receptors in dopamine D1A receptor-deficient mice.
Synapse (New York, N.Y.) 2001;39(4):319-22.
2001: Amit G Gulwadi; Carolyn D Korpinen; Richard B Mailman; David E Nichols; Sing-Yuen Sit; Matthew T Taber
Dinapsoline: characterization of a D1 dopamine receptor agonist in a rat model of Parkinson's disease.
The Journal of pharmacology and experimental therapeutics 2001;296(2):338-44.
2001: Xuemei Huang; Cindy P Lawler; Mechelle M Lewis; David E Nichols; Richard B Mailman
D1 dopamine receptors.
International review of neurobiology 2001;48():65-139.
1999: D M Montague; Cindy P Lawler; Richard B Mailman; John Gilmore
Developmental regulation of the dopamine D1 receptor in human caudate and putamen.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1999;21(5):641-9.
1999: B Hoffman; S J Cho; W Zheng; SD Wyrick; David E Nichols; Richard B Mailman; Alexander Tropsha
Quantitative structure-activity relationship modeling of dopamine D(1) antagonists using comparative molecular field analysis, genetic algorithms-partial least-squares, and K nearest neighbor methods.
Journal of medicinal chemistry 1999;42(17):3217-26.
1999: Cindy P Lawler; C Prioleau; Mechelle M Lewis; C Mak; D Jiang; John A Schetz; A M Gonzalez; David R Sibley; Richard B Mailman
Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1999;20(6):612-27.
1999: M K Doll; David E Nichols; Jason D Kilts; C Prioleau; Cindy P Lawler; Mechelle M Lewis; Richard B Mailman
Synthesis and dopaminergic properties of benzo-fused analogues of quinpirole and quinelorane.
Journal of medicinal chemistry 1999;42(5):935-40.
1998: Jeffrey A Lieberman; Richard B Mailman; Gary E Duncan; Linmarie Sikich; Miranda Chakos; David E Nichols; John E Kraus
Serotonergic basis of antipsychotic drug effects in schizophrenia.
Biological psychiatry 1998;44(11):1099-117.
1998: Gary E Duncan; JN Leipzig; Richard B Mailman; Jeffrey A Lieberman
Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation.
Brain research 1998;812(1-2):65-75.
1998: D R Smith; C D Striplin; A M Geller; Richard B Mailman; J Drago; Cindy P Lawler; Michela Gallagher
Behavioural assessment of mice lacking D1A dopamine receptors.
Neuroscience 1998;86(1):135-46.
1998: Richard B Mailman; David E Nichols
Dopamine D1 receptor agonists as antiparkinson drugs.
Trends in pharmacological sciences 1998;19(7):255-6.
1998: Mechelle M Lewis; Val Watts; Cindy P Lawler; David E Nichols; Richard B Mailman
Homologous desensitization of the D1A dopamine receptor: efficacy in causing desensitization dissociates from both receptor occupancy and functional potency.
The Journal of pharmacology and experimental therapeutics 1998;286(1):345-53.
1998: Aaron Monte; Danuta Marona-Lewicka; Mechelle M Lewis; Richard B Mailman; D B Wainscott; DL Nelson; David E Nichols
Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity.
Journal of medicinal chemistry 1998;41(12):2134-45.
1998: C Andersson; Miranda Chakos; Richard B Mailman; J Lieberman
Emerging roles for novel antipsychotic medications in the treatment of schizophrenia.
The Psychiatric clinics of North America 1998;21(1):151-79.
1998: MA Bunin; C Prioleau; Richard B Mailman; R Mark Wightman
Release and uptake rates of 5-hydroxytryptamine in the dorsal raphe and substantia nigra reticulata of the rat brain.
Journal of neurochemistry 1998;70(3):1077-87.
1997: K Negash; David E Nichols; Val Watts; Richard B Mailman
Further definition of the D1 dopamine receptor pharmacophore: synthesis of trans-6,6a,7,8,9,13b-hexahydro-5H-benzo[d]naphth[2,1-b]azepines as rigid analogues of beta-phenyldopamine.
Journal of medicinal chemistry 1997;40(14):2140-7.
1997: H P Smith; David E Nichols; Richard B Mailman; Cindy P Lawler
Locomotor inhibition, yawning and vacuous chewing induced by a novel dopamine D2 post-synaptic receptor agonist.
European journal of pharmacology 1997;323(1):27-36.
1996: Q D Walker; Richard B Mailman
Triadimefon and triadimenol: effects on monoamine uptake and release.
Toxicology and applied pharmacology 1996;139(2):227-33.
1996: D Ghosh; S E Snyder; Val Watts; Richard B Mailman; David E Nichols
9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: a potent full dopamine D1 agonist containing a rigid-beta-phenyldopamine pharmacophore.
Journal of medicinal chemistry 1996;39(2):549-55.
1996: D M Mottola; S Laiter; Val Watts; Alexander Tropsha; SD Wyrick; David E Nichols; Richard B Mailman
Conformational analysis of D1 dopamine receptor agonists: pharmacophore assessment and receptor mapping.
Journal of medicinal chemistry 1996;39(1):285-96.
1995: Cindy P Lawler; John Gilmore; Val Watts; Q D Walker; S B Southerland; L L Cook; C A Mathis; Richard B Mailman
Interhemispheric modulation of dopamine receptor interactions in unilateral 6-OHDA rodent model.
Synapse (New York, N.Y.) 1995;21(4):299-311.
1995: Val Watts; Cindy P Lawler; A J Gonzales; Q Y Zhou; Olivier Civelli; David E Nichols; Richard B Mailman
Spare receptors and intrinsic activity: studies with D1 dopamine receptor agonists.
Synapse (New York, N.Y.) 1995;21(2):177-87.
1995: SD Wyrick; Raymond G Booth; A M Myers; C E Owens; E C Bucholtz; P C Hooper; Nora S Kula; Ross J Baldessarini; Richard B Mailman
1-Phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes and related derivatives as ligands for the neuromodulatory sigma 3 receptor: further structure-activity relationships.
Journal of medicinal chemistry 1995;38(19):3857-64.
1995: T A Knoerzer; Val Watts; David E Nichols; Richard B Mailman
Synthesis and biological evaluation of a series of substituted benzo[a]phenanthridines as agonists at D1 and D2 dopamine receptors.
Journal of medicinal chemistry 1995;38(16):3062-70.
1995: Jean-Louis Gariépy; PL Gendreau; Richard B Mailman; Manuel Tancer; Mark H Lewis
Rearing conditions alter social reactivity and D1 dopamine receptors in high- and low-aggressive mice.
Pharmacology, biochemistry, and behavior 1995;51(4):767-73.
1995: S E Snyder; F A Aviles-Garay; R Chakraborti; David E Nichols; Val Watts; Richard B Mailman
Synthesis and evaluation of 6,7-dihydroxy-2,3,4,8,9,13b-hexahydro-1H- benzo[6,7]cyclohepta[1,2,3-ef][3]benzazepine, 6,7-dihydroxy- 1,2,3,4,8,12b-hexahydroanthr[10,4a,4-cd]azepine, and 10-(aminomethyl)-9,10- dihydro-1,2-dihydroxyanthracene as conformationally restricted analogs of beta-phenyldopamine.
Journal of medicinal chemistry 1995;38(13):2395-409.
1995: John Gilmore; Val Watts; Cindy P Lawler; E P Noll; David E Nichols; Richard B Mailman
"Full" dopamine D1 agonists in human caudate: biochemical properties and therapeutic implications.
Neuropharmacology 1995;34(5):481-8.
1995: B A Heidenreich; Richard B Mailman; D E Nichols; T Celeste Napier
Partial and full dopamine D1 agonists produce comparable increases in ventral pallidal neuronal activity: contribution of endogenous dopamine.
The Journal of pharmacology and experimental therapeutics 1995;273(1):516-25.
1995: B L Blake; Randy L Rose; Richard B Mailman; PE Levi; Ernest Hodgson
Metabolism of thioridazine by microsomal monooxygenases: relative roles of P450 and flavin-containing monooxygenase.
Xenobiotica; the fate of foreign compounds in biological systems 1995;25(4):377-93.
1995: Val Watts; Cindy P Lawler; D R Fox; Kim A Neve; David E Nichols; Richard B Mailman
LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors.
Psychopharmacology 1995;118(4):401-9.
1995: W K Brewster; David E Nichols; Val Watts; R M Riggs; D Mottola; Richard B Mailman
Evaluation of cis- and trans-9- and 11-hydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridines as structurally rigid, selective D1 dopamine receptor ligands.
Journal of medicinal chemistry 1995;38(2):318-27.
1994: R L Hudkins; Richard B Mailman; D L DeHaven-Hudkins
RLH-033, a novel, potent and selective ligand for the sigma 1 recognition site.
European journal of pharmacology 1994;271(1):235-6.
1994: Dan L Minor; SD Wyrick; P S Charifson; Val Watts; David E Nichols; Richard B Mailman
Synthesis and molecular modeling of 1-phenyl-1,2,3,4-tetrahydroisoquinolines and related 5,6,8,9-tetrahydro-13bH-dibenzo[a,h]quinolizines as D1 dopamine antagonists.
Journal of medicinal chemistry 1994;37(25):4317-28.
1994: T A Knoerzer; David E Nichols; W K Brewster; Val Watts; D Mottola; Richard B Mailman
Dopaminergic benzo[a]phenanthridines: resolution and pharmacological evaluation of the enantiomers of dihydrexidine, the full efficacy D1 dopamine receptor agonist.
Journal of medicinal chemistry 1994;37(15):2453-60.
1994: R L Hudkins; Richard B Mailman; D L DeHaven-Hudkins
Novel (4-phenylpiperidinyl)- and (4-phenylpiperazinyl)alkyl-spaced esters of 1-phenylcyclopentanecarboxylic acids as potent sigma-selective compounds.
Journal of medicinal chemistry 1994;37(13):1964-70.
1994: Mark H Lewis; J L Gariépy; PL Gendreau; D E Nichols; Richard B Mailman
Social reactivity and D1 dopamine receptors: studies in mice selectively bred for high and low levels of aggression.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1994;10(2):115-22.
1994: P Martin; M Ohno; S B Southerland; Richard B Mailman; Kinuko Suzuki
Heterotypic sprouting of serotonergic forebrain fibers in the brindled mottled mutant mouse.
Brain research. Developmental brain research 1994;77(2):215-25.
1994: Manuel Tancer; Richard B Mailman; M B Stein; GA Mason; Stanley W Carson; Robert N Golden
Neuroendocrine responsivity to monoaminergic system probes in generalized social phobia.
Anxiety 1994;1(5):216-23.
1993: Raymond G Booth; SD Wyrick; Ross J Baldessarini; Nora S Kula; A M Myers; Richard B Mailman
New sigma-like receptor recognized by novel phenylaminotetralins: ligand binding and functional studies.
Molecular pharmacology 1993;44(6):1232-9.
1993: Val Watts; Cindy P Lawler; John Gilmore; S B Southerland; David E Nichols; Richard B Mailman
Dopamine D1 receptors: efficacy of full (dihydrexidine) vs. partial (SKF38393) agonists in primates vs. rodents.
European journal of pharmacology 1993;242(2):165-72.
1993: SD Wyrick; Raymond G Booth; A M Myers; C E Owens; Nora S Kula; Ross J Baldessarini; Andrew T McPhail; Richard B Mailman
Synthesis and pharmacological evaluation of 1-phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes as ligands for a novel receptor with sigma-like neuromodulatory activity.
Journal of medicinal chemistry 1993;36(17):2542-51.
1993: Val Watts; Cindy P Lawler; T Knoerzer; M A Mayleben; Kim A Neve; David E Nichols; Richard B Mailman
Hexahydrobenzo[a]phenanthridines: novel dopamine D3 receptor ligands.
European journal of pharmacology 1993;239(1-3):271-3.
1993: Cindy P Lawler; John Gilmore; D H Mooney; M A Mayleben; J R Atashi; B E Mileson; SD Wyrick; Richard B Mailman
A rapid and efficient method for the radiosynthesis and purification of [125I]SCH23982.
Journal of neuroscience methods 1993;49(1-2):141-53.
1993: John Gilmore; Cindy P Lawler; A M Eaton; Richard B Mailman
Postmortem stability of dopamine D1 receptor mRNA and D1 receptors.
Brain research. Molecular brain research 1993;18(4):290-6.
1992: D M Mottola; W K Brewster; L L Cook; David E Nichols; Richard B Mailman
Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist.
The Journal of pharmacology and experimental therapeutics 1992;262(1):383-93.
1991: T W Lovenberg; Robert H Roth; David E Nichols; Richard B Mailman
D1 dopamine receptors of NS20Y neuroblastoma cells are functionally similar to rat striatal D1 receptors.
Journal of neurochemistry 1991;57(5):1563-9.
1991: K J Darney; M H Lewis; W K Brewster; David E Nichols; Richard B Mailman
Behavioral effects in the rat of dihydrexidine, a high-potency, full-efficacy D1 dopamine receptor agonist.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1991;5(3):187-95.
1991: J Satoh; M Irino; P M Martin; Richard B Mailman; Kinuko Suzuki
Neurochemical and immunocytochemical studies of catecholamine system in the brindled mouse.
Journal of neuropathology and experimental neurology 1991;50(6):793-808.
1991: John D Elsworth; M S Lawrence; Robert H Roth; Jane R Taylor; Richard B Mailman; D E Nichols; M H Lewis; D Eugene Redmond
D1 and D2 dopamine receptors independently regulate spontaneous blink rate in the vervet monkey.
The Journal of pharmacology and experimental therapeutics 1991;259(2):595-600.
1991: B E Mileson; M H Lewis; Richard B Mailman
Dopamine receptor 'supersensitivity' occurring without receptor up-regulation.
Brain research 1991;561(1):1-10.
1991: T W Lovenberg; David E Nichols; Eric J Nestler; Robert H Roth; Richard B Mailman
Guanine nucleotide binding proteins and the regulation of cyclic AMP synthesis in NS20Y neuroblastoma cells: role of D1 dopamine and muscarinic receptors.
Brain research 1991;556(1):101-7.
1991: Jane R Taylor; M S Lawrence; D Eugene Redmond; John D Elsworth; Robert H Roth; D E Nichols; Richard B Mailman
Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-induced parkinsonism in monkeys.
European journal of pharmacology 1991;199(3):389-91.
1991: J E Bishop; C A Mathis; J M Gerdes; J M Whitney; A M Eaton; Richard B Mailman
Synthesis and in vitro evaluation of 2,3-dimethoxy-5-(fluoroalkyl)-substituted benzamides: high-affinity ligands for CNS dopamine D2 receptors.
Journal of medicinal chemistry 1991;34(5):1612-24.
1991: P M Martin; M Irino; Kinuko Suzuki; M H Lewis; Richard B Mailman
The female brindled mouse as a model of Menkes' disease: the relationship of fur pattern to behavioral and neurochemical abnormalities.
Developmental neuroscience 1991;13(3):121-9.
1990: W K Brewster; David E Nichols; R M Riggs; D M Mottola; T W Lovenberg; M H Lewis; Richard B Mailman
trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine: a highly potent selective dopamine D1 full agonist.
Journal of medicinal chemistry 1990;33(6):1756-64.
1990: M H Lewis; J P Gluck; A J Beauchamp; M F Keresztury; Richard B Mailman
Long-term effects of early social isolation in Macaca mulatta: changes in dopamine receptor function following apomorphine challenge.
Brain research 1990;513(1):67-73.
1990: Q D Walker; M H Lewis; K M Crofton; Richard B Mailman
Triadimefon, a triazole fungicide, induces stereotyped behavior and alters monoamine metabolism in rats.
Toxicology and applied pharmacology 1990;102(3):474-85.
1989: V R Jimmerson; T M Shih; Donald M Maxwell; A Kaminskis; Richard B Mailman
The effect of 2-(o-cresyl)-4H-1:3:2-benzodioxaphosphorin-2-oxide on tissue cholinesterase and carboxylesterase activities of the rat.
Fundamental and applied toxicology : official journal of the Society of Toxicology 1989;13(3):568-75.
1989: D W Herr; Richard B Mailman; Hugh A Tilson
Blockade of only spinal alpha 1 adrenoceptors is insufficient to attenuate DDT-induced alterations in motor function.
Toxicology and applied pharmacology 1989;101(1):11-26.
1989: P S Charifson; J P Bowen; SD Wyrick; A J Hoffman; M Cory; Andrew T McPhail; Richard B Mailman
Conformational analysis and molecular modeling of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as D1 dopamine receptor ligands.
Journal of medicinal chemistry 1989;32(9):2050-8.
1989: V R Jimmerson; T M Shih; Richard B Mailman
Variability in soman toxicity in the rat: correlation with biochemical and behavioral measures.
Toxicology 1989;57(3):241-54.
1989: T W Lovenberg; W K Brewster; D M Mottola; R C Lee; R M Riggs; David E Nichols; M H Lewis; Richard B Mailman
Dihydrexidine, a novel selective high potency full dopamine D-1 receptor agonist.
European journal of pharmacology 1989;166(1):111-3.
1989: V R Jimmerson; T M Shih; Donald M Maxwell; Richard B Mailman
Cresylbenzodioxaphosphorin oxide pretreatment alters soman-induced toxicity and inhibition of tissue cholinesterase activity of the rat.
Toxicology letters 1989;48(1):93-103.
1989: D M Niedzwiecki; Luigi X Cubeddu; Richard B Mailman
Comparative anticholinergic properties of thioridazine, mesoridazine and sulforidazine.
The Journal of pharmacology and experimental therapeutics 1989;250(1):126-33.
1989: D M Niedzwiecki; Luigi X Cubeddu; Richard B Mailman
Comparative antidopaminergic properties of thioridazine, mesoridazine and sulforidazine on the corpus striatum.
The Journal of pharmacology and experimental therapeutics 1989;250(1):117-25.
1989: D W Herr; Richard B Mailman
Buffer effects on high affinity [3H]-prazosin binding in brain and spinal cord.
Pharmacology, biochemistry, and behavior 1989;32(3):831-4.
1988: P S Charifson; SD Wyrick; A J Hoffman; R M Simmons; J P Bowen; D L McDougald; Richard B Mailman
Synthesis and pharmacological characterization of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as dopamine receptor ligands.
Journal of medicinal chemistry 1988;31(10):1941-6.
1988: D L DeHaven-Hudkins; D W Schulz; T J Walsh; Richard B Mailman
Responses of dopaminergic and serotonergic systems to triethyllead intoxication.
Neurotoxicology and teratology 1988;10(4):279-85.
1988: Clinton D Kilts; C M Anderson; Timothy D Ely; Richard B Mailman
The biochemistry and pharmacology of mesoamygdaloid dopamine neurons.
Annals of the New York Academy of Sciences 1988;537():173-87.
1987: Richard B Mailman
Mechanisms of CNS injury in behavioral dysfunction.
Neurotoxicology and teratology 1987;9(6):417-26.
1987: R J Konkol; L Chapman; George R Breese; Albert M Collier; Clinton D Kilts; Charles Finley; R R Vogel; Richard B Mailman; E G Bendeich
Hemophilus influenzae meningitis in the rat: behavioral, electrophysiological, and biochemical consequences.
Annals of neurology 1987;21(4):353-60.
1987: Kevin M Crofton; L W Reiter; Richard B Mailman
Pyrethroid insecticides and radioligand displacement from the GABA receptor chloride ionophore complex.
Toxicology letters 1987;35(2-3):183-90.
1987: M H Lewis; A A Baumeister; Richard B Mailman
A neurobiological alternative to the perceptual reinforcement hypothesis of stereotyped behavior: a commentary on "Self-stimulatory behavior and perceptual reinforcement".
Journal of applied behavior analysis 1987;20(3):253-8.
1987: Richard B Mailman; M H Lewis
Neurotoxicants and central catecholamine systems.
Neurotoxicology 1987;8(1):123-39.
1986: D L DeHaven; M R Krigman; Richard B Mailman
Temporal changes in dopaminergic and serotonergic function caused by administration of trimethyltin to adult rats.
Neurobehavioral toxicology and teratology 1986;8(5):475-9.
1986: m twery; Brian Kirkpatrick; M H Lewis; Richard B Mailman; CW Cooper
Antagonistic behavioral effects of calcitonin and amphetamine in the rat.
Pharmacology, biochemistry, and behavior 1986;24(5):1203-7.
1986: H Rollema; M G Feenstra; Cor J Grol; M H Lewis; L Staples; Richard B Mailman
S(-)DP-5,6-ADTN as an in vivo dopamine receptor ligand: relation between displacement by dopamine agonists and their pharmacological effects.
Naunyn-Schmiedeberg's archives of pharmacology 1986;332(4):338-45.
1986: T Celeste Napier; B S Givens; D W Schulz; B S Bunney; George R Breese; Richard B Mailman
SCH23390 effects on apomorphine-induced responses of nigral dopaminergic neurons.
The Journal of pharmacology and experimental therapeutics 1986;236(3):838-45.
1986: m twery; Brian Kirkpatrick; E C Critcher; M H Lewis; Richard B Mailman; CW Cooper
Motor effects of calcitonin administered intracerebroventricularly in the rat.
European journal of pharmacology 1986;121(2):189-98.
1986: Richard B Mailman; D W Schulz; Clinton D Kilts; M H Lewis; H Rollema; S Wyrick
The multiplicity of the D1 dopamine receptor.
Advances in experimental medicine and biology 1986;204():53-72.
1986: Richard B Mailman; D W Schulz; Clinton D Kilts; M H Lewis; H Rollema; S Wyrick
Multiple forms of the D1 dopamine receptor: its linkage to adenylate cyclase and psychopharmacological effects.
Psychopharmacology bulletin 1986;22(3):593-8.
1985: D W Schulz; E J Stanford; S W Wyrick; Richard B Mailman
Binding of [3H]SCH23390 in rat brain: regional distribution and effects of assay conditions and GTP suggest interactions at a D1-like dopamine receptor.
Journal of neurochemistry 1985;45(5):1601-11.
1985: Richard B Mailman; Clinton D Kilts
Analytical considerations for quantitative determination of serotonin and its metabolically related products in biological matrices.
Clinical chemistry 1985;31(11):1849-54.
1985: Clinton D Kilts; K L Dew; Timothy D Ely; Richard B Mailman
Quantification of R-(+)-7-chloro-8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-methyl-3- benzazepine in brain and blood by use of reversed-phase high-performance liquid chromatography with electrochemical detection.
Journal of chromatography 1985;342(2):452-7.
1985: D W Schulz; L Staples; Richard B Mailman
SCH23390 causes persistent antidopaminergic effects in vivo: evidence for longterm occupation of receptors.
Life sciences 1985;36(20):1941-8.
1985: M H Lewis; A A Baumeister; D L McCorkle; Richard B Mailman
A computer-supported method for analyzing behavioral observations: studies with stereotypy.
Psychopharmacology 1985;85(2):204-9.
1984: Clinton D Kilts; D L Knight; Richard B Mailman; E Widerlöv; George R Breese
Effects of thioridazine and its metabolites on dopaminergic function: drug metabolism as a determinant of the antidopaminergic actions of thioridazine.
The Journal of pharmacology and experimental therapeutics 1984;231(2):334-42.
1984: D W Schulz; S D Wyrick; Richard B Mailman
[3H]SCH23390 has the characteristics of a dopamine receptor ligand in the rat central nervous system.
European journal of pharmacology 1984;106(1):211-2.
1984: T J Walsh; H A Tilson; D L DeHaven; Richard B Mailman; A Fisher; I Hanin
AF64A, a cholinergic neurotoxin, selectively depletes acetylcholine in hippocampus and cortex, and produces long-term passive avoidance and radial-arm maze deficits in the rat.
Brain research 1984;321(1):91-102.
1984: D L DeHaven; T J Walsh; Richard B Mailman
Effects of trimethyltin on dopaminergic and serotonergic function in the central nervous system.
Toxicology and applied pharmacology 1984;75(2):182-9.
1984: M H Lewis; J N Mobilio; D J Rissmiller; Richard B Mailman
Thioridazine pharmacodynamics: clinical effects may depend upon drug metabolism.
The Journal of the American Osteopathic Association 1984;84(1 Suppl):124-8.
1984: Richard B Mailman; J P Pierce; K M Crofton; J Petitto; D L DeHaven; Clinton D Kilts; M H Lewis
Thioridazine and the neuroleptic radioreceptor assay.
Biological psychiatry 1984;19(6):833-47.
1984: Richard B Mailman; D W Schulz; M H Lewis; L Staples; H Rollema; D L Dehaven
SCH-23390: a selective D1 dopamine antagonist with potent D2 behavioral actions.
European journal of pharmacology 1984;101(1-2):159-60.
1984: D L DeHaven; M R Krigman; J J Gaynor; Richard B Mailman
The effects of lead administration during development on lithium-induced polydipsia and dopaminergic function.
Brain research 1984;297(2):297-304.
1984: Richard B Mailman; D L DeHaven; E A Halpern; M H Lewis
Serum effects confound the neuroleptic radioreceptor assay.
Life sciences 1984;34(11):1057-64.
1984: D M Niedzwiecki; Richard B Mailman; L X Cubeddu
Greater potency of mesoridazine and sulforidazine compared with the parent compound, thioridazine, on striatal dopamine autoreceptors.
The Journal of pharmacology and experimental therapeutics 1984;228(3):636-9.
1984: D W Schulz; Richard B Mailman
An improved, automated adenylate cyclase assay utilizing preparative HPLC: effects of phosphodiesterase inhibitors.
Journal of neurochemistry 1984;42(3):764-74.
1984: D W Schulz; M H Lewis; J Petitto; Richard B Mailman
Ascorbic acid decreases [(3)H]dopamine binding in striatum without inhibiting dopamine-sensitive adenylate cyclase.
Neurochemistry international 1984;6(1):117-21.
1984: CW Cooper; m twery; M H Lewis; Richard B Mailman
Anorectic and other behavioral effects of centrally administered calcitonins.
Psychopharmacology bulletin 1984;20(3):451-5.
1984: I Hanin; M R Krigman; Richard B Mailman
Central neurotransmitter effects of organotin compounds: trials, tribulations and observations.
Neurotoxicology 1984;5(2):267-77.
1983: Richard B Mailman; M H Lewis
Food additives and childhood hyperactivity.
Boletín de la Asociación Médica de Puerto Rico 1983;75(12):551-3.
1983: Richard B Mailman; M H Lewis
Food additives and childhood hyperactivity.
ASDC journal of dentistry for children 1983;50(4):283-6.
1983: m twery; CW Cooper; Richard B Mailman
Calcitonin depresses amphetamine-induced locomotor activity.
Pharmacology, biochemistry, and behavior 1983;18(6):857-62.
1983: M H Lewis; E Widerlöv; D L Knight; Clinton D Kilts; Richard B Mailman
N-oxides of phenothiazine antipsychotics: effects on in vivo and in vitro estimates of dopaminergic function.
The Journal of pharmacology and experimental therapeutics 1983;225(3):539-45.
1983: Richard B Mailman; M R Krigman; G D Frye; I Hanin
Effects of postnatal trimethyltin or triethyltin treatment on CNS catecholamine, GABA, and acetylcholine systems in the rat.
Journal of neurochemistry 1983;40(5):1423-9.
1983: Charles Nemeroff; D Luttinger; D E Hernandez; Richard B Mailman; G A Mason; S D Davis; E Widerlöv; G D Frye; C A Kilts; K Beaumont; George R Breese; A J Prange
Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies.
The Journal of pharmacology and experimental therapeutics 1983;225(2):337-45.
1983: Richard B Mailman
Lithium-induced polydipsia: dependence on nigrostriatal dopamine pathway and relationship to changes in the renin-angiotensin system.
Psychopharmacology 1983;80(2):143-9.
1982: K S Sonstegard; Richard B Mailman; J M Cheek; T E Tomlin; R P DiAugustine
Morphological and cytochemical characterization of neuroepithelial bodies in fetal rabbit lung. I. Studies of isolated neuroepithelial bodies.
Experimental lung research 1982;3(3-4):349-77.
1982: E Widerlöv; J E Häggström; Clinton D Kilts; U Andersson; George R Breese; Richard B Mailman
Serum concentrations of thioridazine, its major metabolites and serum neuroleptic-like activities in schizophrenics with and without tardive dyskinesia.
Acta psychiatrica Scandinavica 1982;66(4):294-305.
1982: E Widerlöv; Clinton D Kilts; Richard B Mailman; Charles Nemeroff; T J Mc Cown; A J Prange; George R Breese
Increase in dopamine metabolites in rat brain by neurotensin.
The Journal of pharmacology and experimental therapeutics 1982;223(1):1-6.
1982: Clinton D Kilts; K S Patrick; George R Breese; Richard B Mailman
Simultaneous determination of thioridazine and its S-oxidized and N-demethylated metabolites using high-performance liquid-chromatography on radially compressed silica.
Journal of chromatography 1982;231(2):377-91.
1982: P Mushak; M R Krigman; Richard B Mailman
Comparative organotin toxicity in the developing rat: somatic and morphological changes and relationship to accumulation of total tin.
Neurobehavioral toxicology and teratology 1982;4(2):209-15.
1981: Clinton D Kilts; George R Breese; Richard B Mailman
Simultaneous quantification of dopamine, 5-hydroxytryptamine and four metabolically related compounds by means of reversed-phase high-performance liquid chromatography with electrochemical detection.
Journal of chromatography 1981;225(2):347-57.
1981: T K Abd-Elraof; W C Dauterman; Richard B Mailman
In vivo metabolism and excretion of propoxur and malathion in the rat: effect of lead treatment.
Toxicology and applied pharmacology 1981;59(2):324-30.
1981: G D Frye; Robert Chapin; R A Vogel; Richard B Mailman; Clinton D Kilts; Robert A Mueller; George R Breese
Effects of acute and chronic 1,3-butanediol treatment on central nervous system function: a comparison with ethanol.
The Journal of pharmacology and experimental therapeutics 1981;216(2):306-14.
1981: R A Vogel; G D Frye; K M Koepke; Richard B Mailman; Robert A Mueller; George R Breese
Differential effects of TRH, amphetamine, naloxone, and fenmetozole on ethanol actions: attenuation of the effects of punishment and impairment of aerial righting reflex.
Alcoholism, clinical and experimental research 1981;5(3):386-92.
1981: C M Kuhn; R A Vogel; Richard B Mailman; Robert A Mueller; S M Schanberg; George R Breese
Effect of 5,7-dihydroxytryptamine on serotonergic control of prolactin secretion and behavior in rats.
Psychopharmacology 1981;73(2):188-93.
1981: Richard B Mailman; M H Lewis
Food additives and developmental disorders: the case of erythrosin (FD&C Red #3), or guilty until proven innocent?
Applied research in mental retardation 1981;2(4):297-305.
1981: Richard B Mailman; M H Lewis; Clinton D Kilts
Animal models related to developmental disorders: theoretical and pharmacological analyses.
Applied research in mental retardation 1981;2(1):1-12.
1981: George R Breese; Robert A Mueller; Richard B Mailman; G D Frye
Effects of TRH on central nervous system function.
Progress in clinical and biological research 1981;68():99-116.
1981: M G Ondrusek; Clinton D Kilts; G D Frye; Richard B Mailman; Robert A Mueller; George R Breese
Behavioral and biochemical studies of the scopolamine-induced reversal of neuroleptic activity.
Psychopharmacology 1981;73(1):17-22.
1980: Richard B Mailman; R M Ferris; F L Tang; R A Vogel; Clinton D Kilts; M A Lipton; D A Smith; Robert A Mueller; George R Breese
Erythrosine (Red No. 3) and its nonspecific biochemical actions: what relation to behavioral changes?
Science (New York, N.Y.) 1980;207(4430):535-7.
1980: R A Vogel; G D Frye; J H Wilson; C M Kuhn; K M Koepke; Richard B Mailman; Robert A Mueller; George R Breese
Attenuation of the effects of punishment by ethanol: comparisons with chlordiazepoxide.
Psychopharmacology 1980;71(2):123-9.
1980: B A Pappas; George R Breese; Richard B Mailman; Robert A Mueller
Importance of the Locus coeruleus and involvement of alpha-adrenergic receptors in the post-decapitation reflex in the rat.
Psychopharmacology 1980;69(2):163-71.
1980: G D Frye; George R Breese; Richard B Mailman; R A Vogel; M G Ondrusek; Robert A Mueller
An evaluation of the selectivity of fenmetozole (DH-524) reversal of ethanol-induced changes in central nervous system function.
Psychopharmacology 1980;69(2):149-55.
1980: G D Frye; R A Vogel; Richard B Mailman; M G Ondrusek; J H Wilson; P A Mueller; George R Breese
A comparison of behavioral and neurochemical effects of ethanol and chlordiazepoxide.
Advances in experimental medicine and biology 1980;132():729-37.
1980: Richard B Mailman; G D Frye; Robert A Mueller; George R Breese
The effects of thyrotropin-releasing hormone (TRH) and other drugs on the actions of alcohol.
Advances in experimental medicine and biology 1980;126():509-22.
1980: R A Vogel; G D Frye; J H Wilson; C M Kuhn; Richard B Mailman; Robert A Mueller; George R Breese
Attenuation of the effect of punishment by thyrotropin-releasing hormone: comparisons with chlordiazepoxide.
The Journal of pharmacology and experimental therapeutics 1980;212(1):153-61.
1979: George R Breese; D B Lundberg; Richard B Mailman; G D Frye; Robert A Mueller
Effect of ethanol on cyclic nucleotides in vivo: consequences of controlling motor and respiratory changes.
Drug and alcohol dependence 1979;4(3-4):321-6.
1979: George R Breese; Robert A Mueller; Richard B Mailman
Effect of dopaminergic agonists and antagonists on in vivo cyclic nucleotide content: relation of guanosine 3':5'- monophosphate (cGMP) changes in cerebellum to behavior.
The Journal of pharmacology and experimental therapeutics 1979;209(2):262-70.
1979: T Kendall Harden; Richard B Mailman; Robert A Mueller; George R Breese
Noradrenergic hyperinnervation reduces the density of beta-adrenergic receptors in rat cerebellum.
Brain research 1979;166(1):194-8.
1979: D B Lundberg; George R Breese; Richard B Mailman; G D Frye; Robert A Mueller
Depression of some drug-induced in vivo changes of cerebellar guanosine 3',5'-monophosphate by control of motor and respiratory responses.
Molecular pharmacology 1979;15(2):246-56.
1979: Richard B Mailman; G D Frye; Robert A Mueller; George R Breese
Change in brain guanosine 3',5'-monophosphate (cGMP) content by thyrotropin-releasing hormone.
The Journal of pharmacology and experimental therapeutics 1979;208(2):169-75.
1978: Charles Nemeroff; Garth Bissette; G H Greeley; Richard B Mailman; J B Martin; P Brazeau; J Kizer
Effects of acute administration of monosodium-L-glutamate (MSG), atropine or haloperidol on anterior pituitary hormone secretion in the rat.
Brain research 1978;156(1):198-201.
1978: Robert A Mueller; D Lundberg; G D Frye; Richard B Mailman; George R Breese
Cerebellar cGMP varies with motor function and respiratory gas exchange.
Neuroscience letters 1978;10(1-2):89-93.
1978: George R Breese; R A Vogel; C M Kuhn; Richard B Mailman; Robert A Mueller; S M Schanberg
Behavioral and prolactin responses to 5-hydroxytryptophan in rats treated during development with 5,7-dihydroxytryptamine.
Brain research 1978;155(2):263-75.
1978: Richard B Mailman; M R Krigman; Robert A Mueller; P Mushak; George R Breese
Lead exposure during infancy permanently increases lithium-induced polydipsia.
Science (New York, N.Y.) 1978;201(4356):637-9.
1978: Richard B Mailman; Robert A Mueller; George R Breese
The effect of drugs which alter GABA-ergic function on cerebellar guanosine-3',5'-monophosphate content.
Life sciences 1978;23(6):623-7.
1978: George R Breese; Richard B Mailman; M G Ondrusek; T Kendall Harden; Robert A Mueller
Effects of dopaminergic agonists and antagonists on cerebellar guanosine-3',5'-monophosphate (cGMP).
Life sciences 1978;23(5):533-6.
1978: George R Breese; Robert A Mueller; A Hollister; Richard B Mailman
Importance of dopaminergic pathways and other neural systems to behavior and action of psychotropic drugs.
Federation proceedings 1978;37(10):2429-33.
1978: Richard B Mailman; G D Frye; Robert A Mueller; George R Breese
Thyrotropin-releasing hormone reversal of ethanol-induced decreases in cerebellar cGMP.
Nature 1978;272(5656):832-3.
1978: R J Konkol; Richard B Mailman; E G Bendeich; A M Garrison; Robert A Mueller; George R Breese
Evaluation of the effects of nerve growth factor and anti-nerve growth factor on the development of central catecholamine-containing neurons.
Brain research 1978;144(2):277-85.
1977: Richard B Mailman; W Edmundson; K Muse; E Hodgson
Multiplicity of hepatic cytochrome P-450 in intact microsomes: effect of 3-methylcholanthrene induction.
General pharmacology 1977;8(4):281-4.
1977: Richard B Mailman; G T Barthalmus; K Muse; E Hodgson
Multiplicity of hepatic cytochrome P-450 in intact microsomes: effect of phenobarbital induction.
General pharmacology 1977;8(4):275-9.
1975: A P Kulkarni; Richard B Mailman; E Hodgson
Cytochrome P-450 optical difference spectra of insecticides. A comparative study.
Journal of agricultural and food chemistry 1975;23(2):177-83.
1975: Richard B Mailman; L G Tate; K E Muse; L B Coons; E Hodgson
The occurrence of multiple forms of cytochrome P-450 in hepatic microsomes from untreated rats and mice.
Chemico-biological interactions 1975;10(3):215-28.
1974: Richard B Mailman; A P Kulkarni; R C Baker; E Hodgson
Cytochrome P-450 difference spectra: effect of chemical structure on type II spectra in mouse hepatic microsomes.
Drug metabolism and disposition: the biological fate of chemicals 1974;2(3):301-8.
1974: A P Kulkarni; Richard B Mailman; R C Baker; E Hodgson
Cytochrome P-450 difference spectra. Type II interactions in insecticide-resistant and -susceptible houseflies.
Drug metabolism and disposition: the biological fate of chemicals 1974;2(3):309-20.
1973: E Hodgson; R M Philpot; R C Baker; Richard B Mailman
Effect of synergists on drug metabolism.
Drug metabolism and disposition: the biological fate of chemicals 1973;1(1):391-401.
1972: R C Baker; L B Coons; Richard B Mailman; E Hodgson
Induction of hepatic mixed function oxidases by the insecticide, mirex.
Environmental research 1972;5(4):418-24.
1972: Richard B Mailman; E Hodgson
The cytochrome P-450 substrate optical difference spectra of pesticides with mouse hepatic microsomes.
Bulletin of environmental contamination and toxicology 1972;8(3):186-92.